Draghia-Akli Ruxandra
EVP, Research & Development · 4 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | NVAX | NOVAVAX INC | Tax withholding | 11,313 | $9.49 | $107,360.37 | filing |
| 2026-03-03 | NVAX | NOVAVAX INC | Option exercise | 26,667 | $0.00 | $0.00 | filing |
| 2025-11-11 | NVAX | NOVAVAX INC | Tax withholding | 6,048 | $7.40 | $44,755.20 | filing |
| 2025-11-11 | NVAX | NOVAVAX INC | Option exercise | 14,257 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.